ERG expression in prostate cancer biopsies with and without high-grade prostatic intraepithelial neoplasia: a study in Jordanian Arab patients
- PMID: 31192172
- PMCID: PMC6535407
- DOI: 10.2147/RRU.S207843
ERG expression in prostate cancer biopsies with and without high-grade prostatic intraepithelial neoplasia: a study in Jordanian Arab patients
Abstract
Background: High-grade prostatic intraepithelial neoplasia (HGPIN) is the most likely precancerous lesion for prostatic adenocarcinoma (PCa). Recent molecular studies have shown that HGPIN can harbor TMPRSS2-ERG fusion, a genetic marker also associated with PCa, which may provide an additional risk stratification tool for HGPIN, especially when present as an isolated lesion. Our aim was to assess the frequency of HGPIN and ERG expression in a cohort of prostatic needle core biopsies from Jordanian-Arab patients with PCa. Materials and methods: We studied 109 needle core biopsies from patients with PCa. Clinical data, including age and preoperative prostate specific antigen (PSA) level, were obtained from patients' medical records. Results: HGPIN was present in 31 (28.4 %) of the 109 cases. Of the HGPIN cases, 13 (41.9%) expressed ERG immunostain. ERG expression in HGPIN was independent of patient age at presentation (P=0.4), pre-operative PSA (P=0.9), and the grade, using the novel Grade Groups (P=0.5). Conclusion: The frequency of HGPIN in our cohort appears similar to the one found in the Western patient populations and demonstrates a comparable frequency of ERG expression in these lesions.
Keywords: ERG; high-grade prostatic intraepithelial neoplasia; immunohistochemistry; prostate carcinoma.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures

Similar articles
-
Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.BJU Int. 2012 Dec;110(11 Pt B):E751-5. doi: 10.1111/j.1464-410X.2012.11557.x. Epub 2012 Oct 9. BJU Int. 2012. PMID: 23046279
-
ERG overexpression and multifocality predict prostate cancer in subsequent biopsy for patients with high-grade prostatic intraepithelial neoplasia.Urol Oncol. 2016 Mar;34(3):120.e1-7. doi: 10.1016/j.urolonc.2015.10.008. Epub 2015 Nov 14. Urol Oncol. 2016. PMID: 26585946
-
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.Clin Cancer Res. 2008 Jun 1;14(11):3380-5. doi: 10.1158/1078-0432.CCR-07-5194. Clin Cancer Res. 2008. PMID: 18519767 Free PMC article.
-
Prostatic intraepithelial neoplasia: an update.Clin Prostate Cancer. 2004 Jun;3(1):26-30. doi: 10.3816/cgc.2004.n.009. Clin Prostate Cancer. 2004. PMID: 15279687 Review.
-
Prostatic intraepithelial neoplasia: its morphological and molecular diagnosis and clinical significance.BJU Int. 2011 Nov;108(9):1394-401. doi: 10.1111/j.1464-410X.2011.010413.x. Epub 2011 Aug 26. BJU Int. 2011. PMID: 21883826 Review.
Cited by
-
A cross-sectional study of ERG expression and the relationship with clinicopathological features of Prostate cancer in Southwestern Uganda.Diagn Pathol. 2024 May 10;19(1):67. doi: 10.1186/s13000-024-01494-1. Diagn Pathol. 2024. PMID: 38730435 Free PMC article.
References
-
- McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Human Pathology 1986;17(1):64–71. - PubMed
-
- Hoedemaeker RF, Kranse R, Rietbergen JB, Kruger AE, Schroder FH, van der Kwast TH. Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions. Cancer. 1999;85(1):145–152. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous